Prometheus Biosciences OverviewPrometheus Biosciences Other Income Expense Net
Other Income/Expense Net for RXDX.
Quarterly Other Income/Expense
$7.83M
↑ 25993.33% YoY
As of Mar 31, 2023
Annual Other Income/Expense (TTM)
$11.82M
↑ 1956.04% YoY
Trailing 12 months ending Mar 31, 2023